Published literature has indicated that ATF4 is significantly highly expressed in CAVD samples, while its poor expression can inhibit the osteogenic differentiation of VICs [14, 20]. The gene discussed is ATF4; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.